Pharma Medical News about immunoassays

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
BMC Immunology, 09/29/09

De Jager W et al. – Systemic cytokine concentrations can serve as surrogate outcome parameters of these interventions to study inflammatory pathways operative in patients in vivo. All together the authors show parameters which are essential for measurement of cytokines in the context of clinical trials.

<< Previous
Boehringer Ingelheim's diabetes pipeline continues to advance as...

Next >>
Salix Pharmaceuticals to Present at JMP Securities Conference

Rapid detection of anti-hepatitis A virus neutralizing antibodies in a microplate enzyme immunoassay
Journal of Medical Microbiology, 10/21/09 Relevance Score: 84%

Comparison of 2 Commercially Available Human Chorionic Gonadotropin Immunoassays Used in the Management of Gestational Trophoblastic Neoplasia
The Journal of Reproductive Medicine, 11/04/09 Relevance Score: 83%

Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing
Future Microbiology, 11/02/09 Relevance Score: 83%

An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories
Vox Sanguinis, 10/15/09 Relevance Score: 82%

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09 Relevance Score: 80%